Trials / NCT07056738
Prospective Exploratory Cohort Study on Ganglion Cell Degeneration in Retinitis Pigmentosa Patients
Enrolling by invitation Observational Natural history / observational
- Sponsor
- University Medical Center Goettingen
- Treatment
- imaging
- Gene
- Not gene-specific
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to no upper limit
- Enrollment
- 130 participants
- Started
- 2025-03-01
- Main results expected
- 2030-03-01
- Results posted
- Not yet
- Record last updated
- 2025-07-09
What the study is testing
The aim of this study is an explorative prospective observation of retinal ganglion cell degeneration and/or inner retina degeneration in Retinitis pigmentosa patients. The rate and patterns of progression will be correlated to the outer retina layers as well as clinical and genetic data of patients. Secondary goal is to determine potential parameters for optogenetic treatment eligibility.
Where it runs
Germany (1)
- EKFZ Else Kroener Fresenius Center for Optogenetic Therapies, University Medical Center Goettingen, Göttingen